Executive Profile*

Daniel S. Lynch M.B.A.

Executive Chairman,Nimbus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 81 board members in 8 different organizations across 14 different industries.

See Board Relationships


Mr. Daniel S. Lynch, also known as Dan, M.B.A., has been the President and Chief Executive Officer at IVREA Pharmaceuticals Inc. since February 1, 2007. Mr. Lynch has been a Venture Partner at Third Rock Ventures, LLC since May 14, 2013. He supports the commercial and business development of existing portfolio companies and serves as a strategic advisor across the portfolio. He has been Executive Chairman at Nimbus Discovery, LLC(Nimbus Therapeutics, Inc.) since November ...

Read Full Background

Corporate Headquarters*

25 First Street
Cambridge, Massachusetts 02141

United States

Phone: 617-588-2655
Fax: 617-231-0652

Board Members Memberships*

Chief Executive Officer, President and Director
Director, Member of Audit Committee and Director of US Oncology Inc
Executive Chairman
Executive Chairman
Executive Chairman


Wesleyan University
Colgate W. Darden Graduate School of Business Administration

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$81,949
Total Calculated Compensation$81,949
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.